Impact of 18F-FDG-PET/CT in Managing a Case of Fungal Prosthetic Valve Endocarditis
PDF
Cite
Share
Request
Interesting Image
E-PUB
6 March 2026

Impact of 18F-FDG-PET/CT in Managing a Case of Fungal Prosthetic Valve Endocarditis

Mol Imaging Radionucl Ther. Published online 6 March 2026.
1. All India Institute of Medical Sciences, Department of Nuclear Medicine, Bhubaneswar, India
2. All India Institute of Medical Sciences, Department of General Medicine, Bhubaneswar, India
No information available.
No information available
Received Date: 22.10.2025
Accepted Date: 20.01.2026
E-Pub Date: 06.03.2026
PDF
Cite
Share
Request

Abstract

Approximately 0.1% of all prosthetic cardiac valves are affected by fungal endocarditis (bacterial endocarditis being the most common cause), which has a high case fatality rate. Post-treatment clinical improvement and a negative blood culture do not definitively rule out the presence of residual active disease. Among imaging techniques, trans-oesophageal echocardiography has higher sensitivity than transthoracic echocardiography, but has its own limitations. Functional imaging with 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) has shown to have high overall sensitivity, specificity, and accuracy for the diagnosis and follow-up evaluation of prosthetic valve infective endocarditis, thereby significantly influencing clinical management. Here, we report a rare case of a patient with Marfan syndrome and fungal prosthetic valve endocarditis, in which 18F-FDG-PET/CT played a significant role in management decision.

Keywords:
Marfan syndrome, fungal endocarditis, 18F-FDG-PET/CT, prosthetic valve endocarditis, Candida endocarditis

Ethics

Informed Consent: The participants signed a consent regarding publishing their data and photographs.

Authorship Contributions

Surgical and Medical Practices: D.S., Concept: K.B., P.S.S.P., G.K.P., K.A., D.S., Design: K.B., P.S.S.P., G.K.P., K.A., D.S., Data Collection or Processing: K.B., P.S.S.P., D.S., Analysis or Interpretation: K.B., P.S.S.P., G.K.P., K.A., D.S., Literature Search: K.B., P.S.S.P., Writing: K.B., P.S.S.P., G.K.P., K.A., D.S.
Conflict of Interest: No conflicts of interest were declared by the authors.
Financial Disclosure: The authors declare that this study has received no financial support.

References

1
Antinori S, Ferraris L, Orlando G, Tocalli L, Ricaboni D, Corbellino M, Sollima S, Galli M, Milazzo L. Fungal endocarditis observed over an 8-year period and a review of the literature. Mycopathologia. 2014;178:37-51.
2
Clancy CJ, Nguyen MH. Non-culture diagnostics for invasive candidiasis: promise and unintended consequences. Journal of Fungi. 2018;4:27.
3
Wang TKM, Sánchez-Nadales A, Igbinomwanhia E, Cremer P, Griffin B, Xu B. Diagnosis of infective endocarditis by subtype using 18f-fluorodeoxyglucose positron emission tomography/computed tomography: a contemporary meta-analysis. Circ Cardiovasc Imaging. 2020;13:e010600.
4
Fowler VG, Durack DT, Selton-Suty C, Athan E, Bayer AS, Chamis AL, Dahl A, DiBernardo L, Durante-Mangoni E, Duval X, Fortes CQ, Fosbøl E, Hannan MM, Hasse B, Hoen B, Karchmer AW, Mestres CA, Petti CA, Pizzi MN, Preston SD, Roque A, Vandenesch F, van der Meer JTM, van der Vaart TW, Miro JM. The 2023 Duke-international society for cardiovascular infectious diseases criteria for infective endocarditis: updating the modified duke criteria. Clin Infect Dis. 2023;77:518-526.
5
Arnold CJ, Johnson M, Bayer AS, Bradley S, Giannitsioti E, Miró JM, Tornos P, Tattevin P, Strahilevitz J, Spelman D, Athan E, Nacinovich F, Fortes CQ, Lamas C, Barsic B, Fernández-Hidalgo N, Muñoz P, Chu VH. Candida infective endocarditis: an observational cohort study with a focus on therapy. Antimicrob Agents Chemother. 2015;59:2365-2373.